Optimum Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 15-11-2024
- Revenue -6.31%
(FY 2023)
- Profit -10.85%
(FY 2023)
- Ebitda 0.20%
(FY 2023)
- Net Worth 24.56%
(FY 2023)
- Total Assets 2.05%
(FY 2023)
About Optimum Therapeutics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 Cr.
Jamal Khan and Sharmin Yaqin serve as directors at the Company.
- CIN/LLPIN
U85100DL2011PTC228675
- Company No.
228675
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Optimum Therapeutics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharmin Yaqin  | Director | 13-Dec-2011 | Current |
| Jamal Khan | Director | 13-Dec-2011 | Current |
Financial Performance of Optimum Therapeutics.
Optimum Therapeutics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.31% decrease. The company also saw a substantial fall in profitability, with a 10.85% decrease in profit. The company's net worth Soared by an impressive increase of 24.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Optimum Therapeutics?
In 2023, Optimum Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Institute Of Cellular Therapies Private LimitedActive 18 years 6 months
Jamal Khan and Sharmin Yaqin are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Jan 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Optimum Therapeutics?
Unlock and access historical data on people associated with Optimum Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Optimum Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimum Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
